Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tapentadol IR vs ER Equivalence in Chronic Low Back Pain
NCT00594516Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Dec 2007
- Primary completion
- Apr 2008
01
Overview
A Phase 3 trial of tapentadol in low back pain (LBP), sponsored by Johnson & Johnson. Started Dec 2007; status: completed.
02
Drugs
tapentadol
03
Conditions
low back pain (LBP)
Beyond the preview
Go deeper on NCT00594516.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00594516.